Professor of Operations & Technology Management
PhD (Georgia Institute of Technology), BEng (National Technical University of Athens)
Research interests
Business analytics and data-driven decision-making processes; technology and R&D management; biopharmaceutical industry.
Subject group: Operations & Technology Management
Professional experience
In addition to his academic work, Nektarios has worked closely on research projects with numerous executives from the biopharmaceutical industry, both in large pharmaceutical organisations and small biotech companies. He has also co-authored the forthcoming book, From Breakthrough to Blockbuster: The Business of Biotechnology.
Awards & honours
- Winner, Best Working Paper Award (for the paper “Project selection and success: insights from the drug development process” (with P. Markou and S. Kavadias), INFORMS TIMES, 2018
- 2nd Prize, POMS PITM College Best Student Paper (Jochen Schlapp), 2015
- 3rd Prize, Best-Paper-Award Innovation Management, for the paper “Resource allocation decisions under imperfect evaluation and organizational dynamics” (with Jochen Schlapp and Vincent Mak), Strascheg Institute for Innovation & Entrepreneurship (SIIE), EBS Business School, 2015
- Cambridge Judge Business School Teaching Award, 2014
- NATO Scholarship for Doctoral Studies, 2006-2007
Selected publications
Here are a selection of Nektarios Oraiopoulos’s publications. Please see the “Selected publications” tab above for a more comprehensive list.
Markou, P., Kavadias, S. and Oraiopoulos, N. (2023) “Rival signals and project selection: insights from the drug development process.” Management Science (DOI: 10.1287/mnsc.2022.4642) (published online Jan 2023)
Drakeman, D.L. and Oraiopoulos, N. (2020) “The risk of de-risking innovation: optimal R&D strategies in ambiguous environments.” California Management Review, 62(3): 42-63 (DOI: 10.1177/0008125620915289)
Agrawal, V. and Oraiopoulos, N. (2020) “The role of decision rights in codevelopment initiatives.” Manufacturing and Service Operations Management, 22(4): 645-867 (DOI: 10.1287/msom.2019.0775)
Neuberger, A., Oraiopoulos, N. and Drakeman, D.L. (2019) “Renovation as innovation: is repurposing the future of drug discovery research?” Drug Discovery Today, 24(1): 1-3 (DOI: 10.1016/j.drudis.2018.06.012)
Neuberger, A., Oraiopoulos, N. and Drakeman, D.L. (2017) “Lemons, or squeezed for resources? Information symmetry and asymmetric resources in biotechnology.” Frontiers in Pharmacology, 8: 338 (DOI: 10.3389/fphar.2017.00338)
Schlapp, J.N., Oraiopoulos, N.and Mak, V. (2015) “Resource allocation decisions under imperfect evaluation and organizational dynamics.” Management Science, 61(9): 2139-2159 (DOI: 10.1287/mnsc.2014.2083)
Journal articles
Oraiopoulos, N., Ferguson, M.E. and Toktay, L.B. (2012) “Relicensing as a secondary market strategy.” Management Science, 58(5): 1022-1037 (DOI: 10.1287/mnsc.1110.1456)
Oraiopoulos, N. and Kavadias, S. (2014) “The path dependent nature of R&D search: implications for (and from) competition.” Production and Operations Management, 23(8): 1450-1461 (DOI: 10.1111/poms.12198)
Schlapp, J.N., Oraiopoulos, N.and Mak, V. (2015) “Resource allocation decisions under imperfect evaluation and organizational dynamics.” Management Science, 61(9): 2139–2159 (DOI: 10.1287/mnsc.2014.2083)
Oraiopoulos, N. and Dunlop, W.C.N. (2017) “When science is not enough: a framework towards more customer-focused drug development.” Advances in Therapy, 34(7): 1572–1583 (DOI: 10.1007/s12325-017-0567-y)
Neuberger, A., Oraiopoulos, N. and Drakeman, D.L. (2017) “Lemons, or squeezed for resources? Information symmetry and asymmetric resources in biotechnology.” Frontiers in Pharmacology, 8: 338 (DOI: 10.3389/fphar.2017.00338)
Neuberger, A., Oraiopoulos, N. and Drakeman, D.L. (2019) “Renovation as innovation: is repurposing the future of drug discovery research?” Drug Discovery Today, 24(1): 1-3 (DOI: 10.1016/j.drudis.2018.06.012)
Drakeman, D.L. and Oraiopoulos, N. (2020) “The risk of de-risking innovation: optimal R&D strategies in ambiguous environments.” California Management Review, 62(3): 42-63 (DOI: 10.1177/0008125620915289)
Agrawal, V. and Oraiopoulos, N. (2020) “The role of decision rights in codevelopment initiatives.” Manufacturing and Service Operations Management, 22(4): 645-867 (DOI: 10.1287/msom.2019.0775)
Oraiopoulos, N. and Kavadias, S. (2020) “Is diversity (un)biased? Project selection decisions in executive committees.” Manufacturing and Service Operations Management, 22(5): 869-1106 (DOI: 10.1287/msom.2019.0782)
Markou, P., Kavadias, S. and Oraiopoulos, N. (2023) “Rival signals and project selection: insights from the drug development process.” Management Science (DOI: 10.1287/mnsc.2022.4642) (published online Jan 2023)
Books, monographs, reports & case studies
Drakeman, D.L., Drakeman, L.N. and Oraiopoulos, N. (2022) From breakthrough to blockbuster: the business of biotechnology. Oxford: Oxford University Press.
